tiprankstipranks
Trending News
More News >
Neuren Pharmaceuticals Limited (NURPF)
OTHER OTC:NURPF
US Market

Neuren Pharmaceuticals Limited (NURPF) Financial Statements

Compare
55 Followers

Neuren Pharmaceuticals Limited Financial Overview

Neuren Pharmaceuticals Limited's market cap is currently $1.10B. The company's EPS TTM is $0.0838331; its P/E ratio is 78.41; Neuren Pharmaceuticals Limited is scheduled to report earnings on February 26, 2026, and the estimated EPS forecast is $0.05. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueAU$ 64.63MAU$ 213.24MAU$ 231.93MAU$ 14.55MAU$ 3.20M
Gross ProfitAU$ 64.61MAU$ 213.22MAU$ 205.17MAU$ 14.54MAU$ 3.19M
Operating IncomeAU$ 22.02MAU$ 175.55MAU$ 172.49MAU$ -1.60MAU$ -11.43M
EBITDAAU$ 22.05MAU$ 175.57MAU$ 199.26MAU$ -670.00KAU$ -10.98M
Net IncomeAU$ 30.44MAU$ 142.04MAU$ 157.08MAU$ 184.00KAU$ -7.79M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 296.12MAU$ 222.24MAU$ 228.54MAU$ 40.18MAU$ 36.78M
Total AssetsAU$ 342.86MAU$ 409.71MAU$ 247.97MAU$ 43.27MAU$ 40.06M
Total DebtAU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Net DebtAU$ -4.23MAU$ -3.15MAU$ -17.09MAU$ -40.18MAU$ -36.78M
Total LiabilitiesAU$ 4.41MAU$ 45.80MAU$ 42.76MAU$ 1.68MAU$ 803.00K
Stockholders' EquityAU$ 338.45MAU$ 363.90MAU$ 205.21MAU$ 41.59MAU$ 39.25M
Cash Flow
Free Cash FlowAU$ 125.39MAU$ -11.28MAU$ 184.88MAU$ 3.58MAU$ -9.98M
Operating Cash FlowAU$ 125.42MAU$ -11.27MAU$ 184.93MAU$ 3.60MAU$ -9.97M
Investing Cash FlowAU$ -88.01MAU$ 4.13MAU$ -211.49MAU$ -19.00KAU$ -10.00K
Financing Cash FlowAU$ -33.22MAU$ -8.78MAU$ 3.62MAU$ -2.00KAU$ 22.18M
Currency in AUD

Neuren Pharmaceuticals Limited Earnings and Revenue History

Neuren Pharmaceuticals Limited Debt to Assets

Neuren Pharmaceuticals Limited Cash Flow

Neuren Pharmaceuticals Limited Forecast EPS vs Actual EPS